Annual report pursuant to Section 13 and 15(d)

NON CONTROLLING INTEREST (Details)

v3.22.1
NON CONTROLLING INTEREST (Details) - USD ($)
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Net loss attributable to the non-controlling interest $ (2,384) $ (34,276)
BioCorRx Pharmaceuticals, Inc [Member]    
Net loss $ (9,853) $ (141,638)
Average Non-controlling interest percentage of profit/losses 24.20% 24.20%
Net loss attributable to the non-controlling interest $ (2,384) $ (34,276)